SCEJ

$B2=3X9)3X2qBh(B87$BG/2q(B($B?@8M(B)

$B9V1i?=$79~$_0lMw!J%7%s%]%8%&%`!&9V1iJ,N`JL!K(B

7) $B%P%$%*(B

7-i. $B$=$NB>(B

$B:G=*99?7F|;~!'(B2022-06-14 16:59:01

$B$3$NJ,N`$G$h$/;H$o$l(B
$B$F$$$k%-!<%o!<%I(B		$B%-!<%o!<%I(B$B
HBV1$B7o(B
Ultrasonic1$B7o(B
polydiacetylene1$B7o(B
Quenchbody (Q-body)1$B7o(B
force direction1$B7o(B
Low Endotoxin Recovery1$B7o(B
Cholane scaffold1$B7o(B
Q-body1$B7o(B
Intracellular endotoxin1$B7o(B
dual-color1$B7o(B
Endotoxin1$B7o(B
E.coli1$B7o(B
Immunoassay1$B7o(B
mechanochromism1$B7o(B
SARS-Cov-21$B7o(B
antibody-conjugated nanoparticles1$B7o(B
Divalent cations1$B7o(B
viral infection1$B7o(B
pore size changes1$B7o(B
Lipid bilayer1$B7o(B
Extracellular endotoxin1$B7o(B
live-cell imaging1$B7o(B
p53 protein1$B7o(B

$B$BHV9f(B$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BH/I=7A<0(B
102$B%]%j%8%"%;%A%l%s!&%a%+%N%/%m%_%:%`$NNOJ}8~0MB8@-(B
($BElBg1!9)(B) ($B3X(B)$B!{=y(B $B@;;R(B$B!&(B ($BElBg@88&(B) ($B@5(B)$B?y86(B $B2C?%(B		polydiacetylene
mechanochromism
force direction
P
228$BBgD26]$rMQ$$$?B??'(BQ-body$B9=C[K!$N3+H/(B
(Tokyo Tech) ($B3X(B)$B!{(BChen Yanmin$B!&(B ($B3X(B)Dai Yancen$B!&(B $BKL8}(B $BE/Li(B$B!&(B ($B@5(B)$B>eED(B $B9((B		Q-body
dual-color
E.coli
P
244Low Endotoxin Recovery$B$KBP1~2DG=$J%(%s%I%H%-%7%sB,DjK!$N3+H/$HMxMQ(B
($BC^GHBg1!@8;q(B) ($B3X(B)$B!{@nyu(B $BK'H~(B$B!&(B ($BC^GHBg@84D(B) ($B@5(B)$B@DLx(B $B=(5*(B		Divalent cations
Endotoxin
Low Endotoxin Recovery
P
382$B:YK&Fb
(Tokyo Tech) ($B3X(B)$B!{(BDai Yancen$B!&(B ($B@5(B)$B$B!&(B $B:4F#(B $BM%;R(B$B!&(B $BLZB<(B $B9((B$B!&(B (A*STAR) Ghadessy Farid J.$B!&(B (Tokyo Tech) $BKL8}(B $BE/Li(B$B!&(B ($B@5(B)$B>eED(B $B9((B		p53 protein
Quenchbody (Q-body)
live-cell imaging
O
468$B3F
($BC^GHBg1!@8;q(B) ($B3X(B)$B!{FA1J(B $B@.H~(B$B!&(B ($BC^GHBg@84D(B) ($B@5(B)$B@DLx(B $B=(5*(B		Extracellular endotoxin
Intracellular endotoxin
Ultrasonic
P
476$BKlF)2a7?%$%`%N%;%s%5$K$*$1$k:Y9&7BJQ2=$rMQ$$$?93868!=PK!$N8!F$(B
($BEl9)Bg2=@88&(B) ($B3X(B)$B!{>.Eg(B $B:Z!9;R(B$B!&(B ($B@5(B)$BBg$B!&(B ($B@5(B)$B;38}(B $BLT1{(B		Immunoassay
pore size changes
antibody-conjugated nanoparticles
P
639$B?77?%3%m%J%&%$%k%95Z$S(BB$B7?4N1j%&%$%k%946@w2A$X$N1~MQ(B
($BElM}Bg1!1~@8(B/$B9qN)46@w8&(B) ($B3X(B)$B!{BgEh(B $BH~7n(B$B!&(B ($B9qN)46@w8&(B) $B4dK\(B $B>-;N(B$B!&(B $BBg66(B $B7<;K(B$B!&(B ($BElM}Bg1!1~@8(B) $BAR;}(B $B9,;J(B$B!&(B ($B9qN)46@w8&(B) $BB<>>(B $B@5F;(B$B!&(B ($BElM}Bg1!1~@8(B/$B9qN)46@w8&(B) $BEO;N(B $B9,0l(B		SARS-Cov-2
HBV
viral infection
O
642$B:YK&KlFbIt$K
($BF`NI9b@l@l962J(B) ($B3X(B)$B!{1sF#(B $B?-9,(B$B!&(B ($BF`NI9b@lJ*$B!&(B ($B0&I2Bg;Y1g%;(B) $B4d:j(B $BCRG7(B$B!&(B ($BF`NI9b@lJ*		Cholane scaffold
Lipid bilayer
P
$B9V1i?=$79~$_0lMw(B($B%7%s%]%8%&%`HV9f!&9V1iJ,N`HV9fJL(B)
$B
$B2=3X9)3X2qBh(B87$BG/2q(B($B?@8M(B)
(C) 2022 $B8x1W
Most recent update: 2022-06-14 16:59:01
For more information contact $B2=3X9)3X2qBh(B87$BG/2q
E-mail: inquiry-87awww3.scej.org
This page was generated by easp 2.47; update.pl 2.37 (C)1999-2015 kawase